OPTINOSE, INC. Net Change in Cash
OPTINOSE, INC. reported Net Change in Cash of -$11.55 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-05-14
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$11.55M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$22.04M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$10.32M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$19.14M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $10.80M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$20.56M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$16.27M.
- OPTINOSE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$33.66M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | -$11.55M 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | $10.80M 10-K · filed 2025-03-26 | ||||
| 2024-09-30 | $8.81M 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $17.67M 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | -$22.04M 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | -$20.56M 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | -$27.40M 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | -$22.93M 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | -$10.32M 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | -$16.27M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | -$49.39M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$32.24M 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$19.14M 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | -$33.66M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$59.94M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$50.25M 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | -$28.19M 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | -$2.99M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$4.02M 10-Q · filed 2021-11-15 | -$4.02M 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | -$21.89M 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | $1.33M 10-Q · filed 2021-05-05 | ||||
| 2019-12-31 | -$53.85M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | -$75.51M 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | -$57.03M 10-Q · filed 2020-08-04 | ||||
| 2019-03-31 | -$29.68M 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | -$33.86M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | -$13.37M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $10.13M 10-Q · filed 2019-08-12 | ||||
| 2018-03-31 | -$25.07M 10-Q · filed 2019-05-09 | ||||
| 2017-09-30 | $12.61M 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | $22.08M 10-Q · filed 2018-08-14 | ||||
| 2017-03-31 | $27.20M 10-Q · filed 2018-05-14 |